As a part of its Corporate Social Responsibility, for the benefit of thalassaemic children, Transasia Bio-Medicals Ltd., once again joined hands with PATUT, to organise ‘Nayaab Lamhe’, a musical concert by the ghazal maestro Padmashree Pankaj Udhas on 2nd March in Mumbai.
For over ten years now, Transasia and Parent Association Thalassaemic Unit Trust (PATUT), have been actively associated in the commitment to the cause of thalassemic children.
Over the last two years, Transasia has organised awareness camps in more than 12 colleges across Mumbai and conducted screening tests on more than 2,500 students. In fact, PATUT and Transasia have together organised numerous dedicated initiatives such as blood donation drives, equipping diagnostic centres with the required instruments and contributing to fund-raising activities for the benefit of thalassaemic children.
“Transasia’s instruments, of international standards, have helped accurately diagnose thalassemia in innumerable patients across the country, giving them a ray of hope,” a statement issued by the company said.
PATUT is a non-profitable organisation set up by parents who leave no stone unturned to ensure that their thalassaemic children get a second chance at life. Through its association with various hospitals, PATUT arranges and mobilises funds for Bone Marrow Transplant (BMT), a last resort procedure for most thalassaemic children. So far, PATUT has arranged funds and sponsored 150 BMTs in the last five years.
Speaking at the occasion, Suresh Vazirani, Chairman & Managing Director, Transasia said, “From helping four children in 1982 to establishing centres for spreading awareness, detection, counselling and prevention of thalassemia, the impact of the good work done by PATUT has spread far and beyond. At Transasia, we believe in operating with a higher purpose, with an unwavering focus on our customers and the patients they serve. Thalassemia is a cause we very closely associate with. We are glad that with our haematology range of analysers, we are able to contribute to the early and accurate diagnosis of thalassemia and its associated adversities, giving the patients a chance for timely treatment.”
More than 400 pathologists from across the city, attended the event on behalf of Transasia. Dr. V. H. Juvekar, General Manager, Haffkine Biopharmaceutical Corporation Ltd. remarked, “Thalassemia is a growing concern for the country. Today, 35-45 million Indians, are carriers of beta-thalassemia, which translates to 3-4% of India’s population. It is heart rending to see so many young children, losing their lives to the condition, for want of a Bone Marrow Transplant. Transasia and PATUT are doing a splendid job, to reach out to these children.”
